Does 'male menopause' exist? What andropause claims get wrong
Quick answer
The creator correctly challenges the clinical utility of 'andropause' as a diagnosis, noting that gradual testosterone decline is multifactorial and often reversible. However, symptomatic late-onset hypogonadism is a recognized condition in Endocrine Society and AUA guidelines, requiring two low morning testosterone readings alongside specific symptoms before treatment is considered. The mention of tramadol and opioid-induced androgen deficiency is clinically accurate and underemphasized in mainstream health content.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @doctorsooj actually say?
The short version: the term "andropause" is misleading, and most men's midlife symptoms are not simply caused by falling testosterone. @doctorsooj argued that testosterone drops "about 1% a year from the age of 30 or 40" but that this decline is "unlikely to cause any problems in itself." They also named specific contributors to low testosterone beyond age, including diet, BMI, androgenic supplement use, and opioid medications like tramadol.
This is a more nuanced take than most TikTok health content. The creator is pushing back against a popular oversimplification, not selling a treatment. That framing matters when evaluating what they got right and what they left out.
Does the science back this up?
Largely, yes. The 1% annual decline figure is well-supported, and the caution around the "andropause" label is shared by mainstream endocrinology. But the claim that gradual testosterone decline is "unlikely to cause problems" is where things get more complicated.
The Massachusetts Male Aging Study (Feldman et al., 2002, Journal of Clinical Endocrinology and Metabolism) confirmed that total testosterone falls roughly 1.6% per year, with free testosterone declining faster at around 2-3% annually. That gap matters clinically. A 2020 meta-analysis by Rastrelli et al. in Nature Reviews Urology found that symptomatic late-onset hypogonadism, meaning men with both low testosterone and specific symptoms, is a real and underdiagnosed condition affecting an estimated 2-6% of middle-aged men. So while the term "andropause" is genuinely misleading because it implies a sudden, universal hormonal shift comparable to female menopause, dismissing the entire symptom cluster as unrelated to testosterone isn't fully accurate either.
The opioid connection, specifically tramadol, is well-documented. Opioid-induced androgen deficiency (OPIAD) is recognized in the clinical literature (Vuong et al., 2010, Journal of Endocrinology).
What did they get wrong (or right)?
They got the core framing right. "Andropause" is not an accurate biological equivalent to menopause. Female menopause involves a rapid, near-complete loss of ovarian estrogen production. Male testosterone decline is gradual, variable, and heavily influenced by lifestyle, as the creator correctly stated.
Where the video falls short is the suggestion that gradual decline is unlikely to cause problems. This risks dismissing men who genuinely have symptomatic hypogonadism. The Endocrine Society's 2018 clinical practice guidelines explicitly state that testosterone therapy is appropriate for men with consistently low serum testosterone and unambiguous symptoms, after ruling out reversible causes. The creator's list of reversible causes (BMI, diet, opioids, supplements) is accurate and useful. But stopping there without acknowledging that true hypogonadism exists and can be treated leaves the picture incomplete.
No misinformation here, but a notable omission that could lead men with legitimate hormonal deficiencies to dismiss their symptoms as purely lifestyle-related.
What should you actually know?
If you're a man in your 40s or 50s experiencing fatigue, low libido, muscle loss, or mood changes, the honest answer is that testosterone might be a factor, but it is rarely the only one. Sleep disorders, depression, metabolic syndrome, and thyroid dysfunction all produce nearly identical symptoms and are far more common than true hypogonadism.
A proper workup means more than one early-morning total testosterone measurement. Free testosterone, luteinizing hormone, sex hormone-binding globulin, and a full metabolic panel give a clearer picture. The American Urological Association defines low testosterone as below 300 ng/dL on two separate morning tests, with accompanying symptoms.
The creator's point about tramadol is worth taking seriously. Opioid use is a frequently overlooked and reversible cause of low testosterone in men. If you're on long-term opioid therapy and experiencing these symptoms, that conversation with your prescriber is worth having before assuming age-related decline is the culprit.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 8 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Does 'male menopause' exist? What andropause claims get wrong, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
NAD+ metabolism and its roles in cellular processes during ageing
Core review for NAD+ decline, mitochondrial function, DNA repair, and aging biology.
PubMed
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
Human NMN source for metabolic claims while keeping population limits clear.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
Does 'male menopause' exist? What andropause claims get wrong is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
Compare providers, services and access requirements in the directory before contacting a suitable care team.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Claim verdict
The useful answer behind this video
Claim being checked
The creator correctly challenges the clinical utility of 'andropause' as a diagnosis, noting that gradual testosterone decline is multifactorial and often reversible.
FormBlends verdict
The creator correctly challenges the clinical utility of 'andropause' as a diagnosis, noting that gradual testosterone decline is multifactorial and often reversible. However, symptomatic late-onset hypogonadism is a recognized condition in Endocrine Society and AUA guidelines, requiring two low morning testosterone readings alongside specific symptoms before treatment is considered. The mention of tramadol and opioid-induced androgen deficiency is clinically accurate and underemphasized in mainstream health content.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- The creator correctly challenges the clinical utility of 'andropause' as a diagnosis, noting that gradual testosterone decline is multifactorial and often reversible. However, symptomatic late-onset hypogonadism is a recognized condition in Endocrine Society and AUA guidelines, requiring two low morning testosterone readings alongside specific symptoms before treatment is considered. The mention of tramadol and opioid-induced androgen deficiency is clinically accurate and underemphasized in mainstream health content.
- Total testosterone falls roughly 1.6% per year after age 30, but free testosterone drops faster at 2-3% annually, making free testosterone the more clinically relevant marker (Feldman et al., 2002).
- Symptomatic late-onset hypogonadism is real and affects an estimated 2-6% of middle-aged men, meaning gradual decline can cause problems in a meaningful subset of men (Rastrelli et al., 2020).
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Total testosterone falls roughly 1.6% per year after age 30, but free testosterone drops faster at 2-3% annually, making free testosterone the more clinically relevant marker (Feldman et al., 2002).
- Symptomatic late-onset hypogonadism is real and affects an estimated 2-6% of middle-aged men, meaning gradual decline can cause problems in a meaningful subset of men (Rastrelli et al., 2020).
- The Endocrine Society and AUA both require two separate early-morning testosterone readings below 300 ng/dL plus specific symptoms before a hypogonadism diagnosis is made.
- Tramadol and other opioids can directly suppress testosterone production through a recognized mechanism called opioid-induced androgen deficiency (OPIAD), which is reversible if opioid use stops.
- Fatigue, low libido, and muscle loss in men over 40 overlap heavily with symptoms of depression, sleep apnea, and thyroid disease, all of which must be ruled out before attributing symptoms to testosterone.
- Obesity independently lowers testosterone by increasing aromatase activity, which converts testosterone to estrogen. Weight loss alone can raise testosterone levels without any pharmacological intervention.
- The term 'andropause' is rejected by mainstream endocrinology bodies because male hormone decline has no biological equivalent to the rapid, complete estrogen loss that defines female menopause.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Dr Sooj | MBBS BSc MRCGP · TikTok creator
115.9K views on this video
Does the ‘male menopause’ exist? #doctor #andropause #testosterone #menshealth #fatigue
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Not medical advice. This video was made by Dr Sooj | MBBS BSc MRCGP, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.